Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer.

Weigel, M T; Banerjee, S; Arnedos, M; Salter, J; A'Hern, R; Dowsett, M; Martin, L A

Weigel, M T; Banerjee, S; Arnedos, M; Salter, J; A'Hern, R; Dowsett, M; Martin, L A.

Affiliation

Weigel MT; The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

Ann Oncol ; 24(1): 126-33, 2013 Jan.

Article in En | MEDLINE | ID: mdl-22865780

Subject(s)

Aromatase Inhibitors/therapeutic use; Breast Neoplasms/metabolism; Oncogene Proteins v-abl/metabolism; Receptors, Platelet-Derived Growth Factor/metabolism; Signal Transduction; Adult; Aged; Biomarkers/metabolism; Breast Neoplasms/drug therapy; Drug Resistance, Neoplasm; Female; Humans; Immunohistochemistry; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Signal Transduction / Oncogene Proteins v-abl / Receptors, Platelet-Derived Growth Factor / Aromatase Inhibitors Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google